Global Seirin Pyonex Needles Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Seirin Pyonex Needles market size was valued at US$ 579 million in 2025 and is forecast to a readjusted size of US$ 995 million by 2032 with a CAGR of 7.3% during review period.
Seirin Pyonex Needles refer to disposable sterile intradermal needle devices developed and manufactured by Seirin Corporation of Japan, belonging to the category of micro-needles within traditional Chinese acupuncture instruments. Their core characteristics lie in the extremely short needle body and the needle handle pre-attached to a medical microporous adhesive tape. By shallow insertion into the intradermal layer and retention for several hours to days, they achieve sustained and gentle acupoint stimulation. From an industry perspective, this product is a typical outcome of the deep integration of traditional acupuncture therapy with modern precision manufacturing technology. In 1978, Seirin Corporation pioneered the global development of disposable sterile acupuncture needles, launched its press needle product in 2004, and established a representative office in China in 2013 to enter the Chinese market. Its patented sealed plastic structure enables aseptic operation where the operator never contacts the needle tip, and the product has obtained market access certifications from major global authorities including the US FDA, EU CE, and China's NMPA, with sales reaching over 40 countries and regions worldwide. According to the US FDA GUDID database, the product has GMDN code 34175, defined as a slender sharp instrument used to stimulate peripheral nerves to produce therapeutic effects, with FDA product code MQX. In China, its registration certificate number is Guoxie Jinzhu 20162201259, valid until 2026, with the National Medical Products Administration's latest approval document in September 2025 confirming its continued registration validity.
Market Development Opportunities and Key Drivers
In 1978, Seirin Corporation pioneered the global development of disposable sterile acupuncture needles, fundamentally changing the cross-infection risks associated with needle reuse. Over the following forty-plus years, the company continuously advanced automated and unmanned production processes. In 2017, the China Economic and Social Council disclosed that Seirin's production workshop had achieved unmanned automation, with quality surpassing that of Chinese enterprises. Seirin holds multiple patents, and its products have entered over 40 countries and regions worldwide, holding a domestic market share exceeding 70 percent in Japan while also occupying a dominant position in premium markets such as Europe and North America.
Market Challenges and Risks
Seirin's success reflects the collective predicament of China's domestic acupuncture needle industry. In 2017, the People's Political Consultative News reported that nearly all acupuncture needles used globally a decade prior were made in China, yet by 2017, Chinese manufacturing accounted for less than one-third of the global market, with production capacity lagging behind South Korea and quality lagging behind Japan. Seirin of Japan employs unmanned, automated processes, while Chinese companies such as Huatuo and Jiajian remain in a semi-mechanized state. The ISO standard for disposable sterile acupuncture needles, drafted under China's leadership, had its technical parameters made publicly available, allowing Japanese and South Korean companies to master the technical specifications and leverage WTO liberalization policies to capture market share. Foreign enterprises enjoy tax incentives, while domestic traditional companies lack access to dedicated funding channels. Currently, Seirin products are priced at 12 yuan per unit in winning bids at tertiary hospitals such as those in Shenzhen and Beijing, still occupying a premium price tier.
Downstream Demand Trends
A 2025 study from Lanzhou University First Hospital demonstrated that press needles significantly reduce the incidence of moderate to severe postoperative pain within 72 hours following gastric endoscopic submucosal dissection. Research published in Guangzhou Medical Journal confirmed that the combination of wrist-ankle acupuncture and press needles achieved a total effective rate of 92.5 percent in treating postherpetic neuralgia. The Chinese Journal of General Practice reported that press needles combined with Vitamin D therapy achieved a total effective rate of 90.0 percent in children with autism spectrum disorder. A study in the Journal of Practical Clinical Medicine showed that press needle therapy combined with intratympanic injection effectively alleviated inflammatory responses and improved inner ear blood circulation in the treatment of sudden sensorineural hearing loss. Seirin products continue to be procured through ongoing tenders at multiple tertiary hospitals in Shenzhen and Beijing, demonstrating stable clinical demand.
Regional Trends
Seirin of Japan, leveraging its unmanned production technology, occupies the premium segment of the global market, holding a domestic market share exceeding 70 percent and exporting to over 40 countries and regions. South Korean brands such as Dongbang and Haenglim occupy the mid-tier market, while Chinese acupuncture needle products largely remain at the lower end. In the Chinese market, Seirin established its representative office in 2013 and obtained its NMPA registration certificate in 2016. Its products have entered the procurement catalogs of tertiary hospitals including Beijing Chaoyang Hospital and Shenzhen Second People's Hospital, with a winning bid price of 12 yuan per unit, establishing a clear price differentiation from domestic brands. The increasingly stringent regulation of acupuncture needle production in China provides a more favorable market environment for compliant enterprises such as Seirin.
This report is a detailed and comprehensive analysis for global Seirin Pyonex Needles market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Seirin Pyonex Needles market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Seirin Pyonex Needles market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Seirin Pyonex Needles market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Seirin Pyonex Needles market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Seirin Pyonex Needles
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Seirin Pyonex Needles market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seirin, Haenglim Medical, Dongbang AcuPrime, Dana Medical, asia-med GmbH, Jiachen Acupuncture, Jiajian Medical Instrument, Hualun Medical, Zhongyan Taihe Medical Instrument, Oriental Acupuncture Equipment Plant, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Seirin Pyonex Needles market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Grain-Type Needle
Thumbtack-Type Needle
Market segment by Needle Length
Ultra-Short Type
Short Type
Medium Type
Market segment by Needle Diameter
0.11mm Type
0.15mm Type
0.17mm Type
0.20mm Type
Market segment by Usage Site
Body Acupoint Needle
Ear Acupoint Needle
Market segment by Application
Pain Management
Postoperative Care
Otolaryngology
Major players covered
Seirin
Haenglim Medical
Dongbang AcuPrime
Dana Medical
asia-med GmbH
Jiachen Acupuncture
Jiajian Medical Instrument
Hualun Medical
Zhongyan Taihe Medical Instrument
Oriental Acupuncture Equipment Plant
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Seirin Pyonex Needles product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Seirin Pyonex Needles, with price, sales quantity, revenue, and global market share of Seirin Pyonex Needles from 2021 to 2026.
Chapter 3, the Seirin Pyonex Needles competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Seirin Pyonex Needles breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Seirin Pyonex Needles market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Seirin Pyonex Needles.
Chapter 14 and 15, to describe Seirin Pyonex Needles sales channel, distributors, customers, research findings and conclusion.